Day 1 | Updates in CLL - William Wierda, MD, PhD – MD Anderson Cancer Center
In this session, Dr William Wierda reviews recent developments in CLL treatment, focusing on targeted therapies and their impact on patient outcomes.
▶︎
What's New with CLL Treatments w/Top Expert | Dr. William Wierda, MD Anderson | The Patient Story
▶︎
Before you Start or Refuse Cancer Therapy- WATCH THIS!
▶︎
Management of HER2 Low and HER2 Ultra Low - Greg Vidal, MD, PhD
▶︎
Treating Oligometastatic Prostate Cancer in the PSMA PET Era with Dr. Andrew W. Hahn, MD
▶︎
Stress Testing: So Many Types, I Am Confused! (Miguel A Quiñones, MD)
▶︎
NSCLC: Essential NGS Testing, Biomarkers, and Targeted Therapies - Shayma Kazmi, MD, RPh
▶︎
What’s New in Chronic Lymphocytic Leukemia (CLL)?
▶︎
Updates in Non Prostate Urogenital Cancers - Sandy Srinivas, MD
▶︎
Improving Transdermal Fentanyl Prescribing
▶︎
Dr. Glenn Bauman - Beyond progression-free survival for prostate cancer: Key insights | CRLS 2026
▶︎
Watch Drs. Wierda, Allan & Lamanna discuss #CLL updates from #SOHO2024 https://bit.ly/CLLHouston24Y
▶︎
Day 1 | Updates in Colorectal Cancer - Heinz-Josef Lenz, MD – Keck Medicine of USC
▶︎
JCO at ASCO 2026: Intravesical Recombinant BCG with Chemo-Immunotherapy in MIBC
▶︎
Personalized Medicine in Ovarian Cancer – Pier Paolo Claudio, MD
▶︎
ASH 2025 Expert Insights: A New BTK Degrader Shows Promise in R/R CLL
▶︎
How Proctor’s texts in Karen Read lawsuit could free dangerous criminals
▶︎
Counseling Men with Favorable Intermediate Risk Prostate Cancer: How to Advise? by Dov Kadmon, MD
▶︎
CLL / Chronic Lymphocytic Leukemia: EXPLAINED!
▶︎
Anktiva's Dirty Secret | Why Many Patients Can't Benefit? #DrPatrickSoon-Shiong #Anktiva
▶︎